A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

August 11, 2025

Study Completion Date

August 11, 2025

Conditions
Acute Migraine
Interventions
DRUG

Elismetrep (K-304) Dose Level 1

Administered orally

DRUG

Elismetrep (K-304) Dose level 2

Administered orally

DRUG

Elismetrep (K-304) Dose level 3

Administered orally

DRUG

Elismetrep (K-304) Dose level 4

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (66)

13104

CNY Clinical Research, Manlius

14221

Upstate Clinical Research Associates LLC, Williamsville

14226

Dent Neurosciences Research Center, Amherst

14609

Rochester Clinical Research, Rochester

15478

Frontier Clinical Research, LLC, Smithfield

15683

Frontier Clinical Research, LLC, Scottdale

18103

Lehigh Center for Clinical Research, Allentown

19114

Clinical Research Philadelphia, LLC, Philadelphia

19380

Atlas-Clinical, West Chester

23606

Health Research of Hampton Roads, Inc., Newport News

26505

Frontier Clinical Research, LLC, Morgantown

27260

Peters Medical Research, High Point

27405

Headache Wellness Center, Greensboro

29405

Coastal Carolina Research Center, North Charleston

29406

Clinical Trials of South Carolina, Charleston

30281

Clinical Research Atlanta - Stockbridge, Stockbridge

30329

DelRicht Research, Atlanta

35205

Central Research Associates, LLC (CRA) dba Flourish Research, Birmingham

36608

AMR Mobile, Mobile

37203

Clinical Research Associates, Inc., Nashville

37421

WR-ClinSearch, Chattanooga

37909

AMR Knoxville (Formerly NOCCR), Knoxville

39503

DelRicht Research, Gulfport

40213

L-MARC Research Center, Louisville

45212

CTI Clinical Research Center, Cincinnati

48104

Michigan Head Pain and Neurological Institute, Ann Arbor

53144

Clinical Investigation Specialist, Kenosha

55402

Clinical Research Institute, Minneapolis

60422

Healthcare Research Network II, LLC, Flossmoor

60607

Cedar Crosse Research Center, Chicago

63042

Healthcare Research Network, Hazelwood

66202

Collective Medical Research, Overland Park

67207

Alliance for Multispecialty Research, Wichita

70043

Crescent City Headache & Neurology Center, Chalmette

70115

DelRicht Research, New Orleans

73034

OK Clinical Research, LLC, Edmond

73099

Tekton Research, Yukon

73102

Hightower Clinical, Oklahoma City

74133

DelRicht Research, Tulsa

75165

ClinPoint Trials, Waxahachie

75251

FutureSearch Trials of Dallas, LP, Dallas

77024

Victorium Clinical Research LTD CO, Houston

77372

APD Clinical Research, Splendora

78737

Donald J Garcia Jr, MD, PA, Austin

78745

Tekton Research, Austin

83704

Northwest Clinical Trials, Boise

84405

Advanced Research Institute, Ogden

85710

Wake Research/ Tucson Neuroscience Research, Tucson

87102

Albuquerque Clinical Trials, Inc., Albuquerque

89109

Acclaim Clinical Research, San Diego

Excel Clinical Research, Las Vegas

89119

Las Vegas Clinical Trials, North Las Vegas

91303

Hope Clinical Research, Canoga Park

91307

Focus Clinical Research, West Hills

91316

WR-PRI, LLC (Encino), Encino

91767

Empire Clinical Research, Pomona

91942

Eximia Research - CA, La Mesa

91945

Synergy San Diego, Lemon Grove

92056

Excell Research, Inc., Oceanside

92103

Artemis Institute for Clinical Research - San Diego, San Diego

92503

Artemis Institute for Clinical Research - Riverside, Riverside

92647

Marvel Clinical Research, Huntington Beach

92660

WR-PRI, LLC (Newport Beach), Newport Beach

94598

Diablo Clinical Research, Inc., Walnut Creek

97210

Summit Research Network, Portland

06416

CT Clinical Research, Cromwell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kallyope Inc.

INDUSTRY